FOLLOW US

  • facebook
  • twitter
Tue

March 2, 2026

Sobi to Acquire Arthrosi Therapeutics

America December 15, 2025

Sobi to Acquire Arthrosi Therapeutics in $1.5B Gout Drug Bet

Swedish biopharmaceutical company Swedish Orphan Biovitrum AB said Monday it has struck a deal to buy Arthrosi Therapeutics Inc., a…

By Rihem Akkouche

J&J Bellwether LA suit

America November 14, 2025

J&J Bellwether LA Suit Opens With Explosive Allegations Over Talc and Cancer Risks

A high-stakes bellwether trial that could shape the trajectory of thousands of talc-cancer claims nationwide erupted Thursday with accusations that…

By Rihem Akkouche

Day One to acquire Mersana Therapeutics

America November 14, 2025

Day One to Acquire Mersana Therapeutics in High-Stakes $285M Cancer Drug Deal

In a dramatic move that reshapes the biopharma landscape, Day One Biopharmaceuticals revealed Thursday that it will acquire Mersana Therapeutics…

By Rihem Akkouche

MapLight $251M IPO

America October 27, 2025

MapLight $251M IPO Defies Market Slowdown Amid Federal Shutdown

In a bold move against a backdrop of federal uncertainty, MapLight Therapeutics has gone public, raising $251 million in its…

By Rihem Akkouche

Drugs Made In America $500M In IPO

America September 25, 2025

Drugs Made In America $500M In IPO Marks 2025’s Biggest SPAC Debut

Wall Street’s appetite for risk lit up again Thursday as Drugs Made In America Acquisition II stormed onto the Nasdaq,…

By Rihem Akkouche

Novartis, Monte Rosa $5.7B Deal

America September 15, 2025

Novartis, Monte Rosa $5.7B Deal Targets Immune Diseases

In a bold wager on next-generation drug discovery, Novartis, Monte Rosa $5.7B Deal is set to reshape the landscape of…

By Rihem Akkouche

Merck $2B China Cardio Drug Bet

America March 25, 2025

Merck Makes Bold $2B Bet on Chinese Cardio Drug

Merck & Co. Inc. is making a high-stakes move in the cardiovascular drug market, announcing on Tuesday an exclusive licensing…

By Rihem Akkouche

astrazeneca $2.5b investment

America March 21, 2025

AstraZeneca invests $2.5B in China for R&D

In a bold move to cement its foothold in China’s booming biopharmaceutical sector, AstraZeneca announced Friday a $2.5 billion investment…

By Rihem Akkouche

America May 25, 2024

Fox Rothschild Adds Surgeon-Turned-Attorney Paul Zagar to IP Team

Fox Rothschild LLP is bringing on a surgeon-turned-attorney with experience in patent advising within biotech, chemicals, and pharmaceuticals to its…

By Rochdi Rais

Novo Nordisk to buy heart drugmaker for $1.1B

America March 25, 2024

Novo Nordisk to buy heart drugmaker for $1.1B

In a groundbreaking move, Novo Nordisk A/S, the Danish pharmaceutical juggernaut, has set its sights on Cardior Pharmaceuticals of Germany,…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter